Amazed by PM Modi's knowledge of vaccines, says SII's Adar Poonawalla
Pune-based Serum Institute of India is conducting the phase 3 trials of AztraZennca and Oxford University's Covid-19 vaccine candidate Covishield
'Had a good interaction with the team at Serum Institute of India', PM Modi tweeted
Pune: Hours after Prime Minister Narendra Modi visited Pune-based Serum Institute of India (SII), its Chief Executive Officer Adar Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and vaccine production.
Poonawalla said they are in the process of applying for emergency-use authorisation of the COVID-19 vaccine candidate in the next two weeks. "Implementation can only happen after the emergency-use licence is obtained. The licence will be granted based on the data submitted by us. We are in the process of submitting the data to the Drug Controller of India," he said.
Earlier in a tweet, Adar Poonawalla said; "Sri @narendramodi Ji, it was a great honour for you to have spared the time, to visit us here at @SerumInstIndia to discuss in detail, the complex challenges yet to come and review the vaccine production status. @PMOIndia"
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!